Location History:
- Victoria, AU (2012)
- Armadale, AU (2013)
- Notting Hill, AU (2013 - 2016)
Company Filing History:
6 out of 54 
1 out of 5 Years Active: 2012-2016
Title: Michael Harding: Innovator in Viral Polymerase Inhibitors
Introduction
Michael Harding is a notable inventor based in Notting Hill, Australia. He has made significant contributions to the field of virology, particularly through his work on viral polymerase inhibitors. With a total of seven patents to his name, Harding's innovations are aimed at combating viral infections, including those caused by the Hepatitis C virus.
Latest Patents
Among his latest patents, Harding has developed viral polymerase inhibitors that are described by a specific formula. These inhibitors, along with their salts, N-oxides, solvates, hydrates, racemates, enantiomers, or isomers, are designed for use in the treatment of Flaviviridae viral infections, such as Hepatitis C virus (HCV) infections. His work in this area represents a significant advancement in therapeutic options for patients suffering from these viral infections.
Career Highlights
Throughout his career, Michael Harding has worked with several prominent companies in the biotechnology sector. Notably, he has been associated with Biota Scientific Management Pty Ltd and Aviragen Therapeutics, Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in viral treatment.
Collaborations
Harding has collaborated with various professionals in his field, including Alistair George Draffan and Silas Bond. These collaborations have further enriched his research and development efforts, leading to innovative solutions in virology.
Conclusion
Michael Harding's contributions to the field of viral polymerase inhibitors highlight his role as a key innovator in the fight against viral infections. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.